Table 3 Timeframes for the treatment of AKI at RFH
Time period | Number of patients treated | Median (IQR) time to treatment (min) | P value | |
|---|---|---|---|---|
Sepsis, infection and hypovolaemia | Before implementation | 223 | 114.0 (50.0–216.5) | 0.288 |
After implementation | 196 | 100.0 (45.0–195.2) | ||
Nephrotoxicity | Before implementation | 28 | 207.5 (145.8–313.5) | 0.047 |
After implementation | 43 | 145.0 (105.5–224.5) | ||
Obstruction | Before implementation | 27 | 268.0 (186.5–632.5) | 0.498 |
After implementation | 31 | 224.0 (114.5–875.5) | ||
Primary renal disease | Before implementation | 8 | 515.5 (203.8–1295.5) | 0.345 |
After implementation | 6 | 1087.0 (537.0–1602.0) |